# : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)

> **NCT03445793** · — · COMPLETED · sponsor: **National Jewish Health** · enrollment: 5 (actual)

## Conditions studied

- Cystic Fibrosis (CF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03445793
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03445793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03445793, ": TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03445793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*